A reduction in TRIM11 protein levels has been reported in Alzheimer's disease (AD) brains, and TRIM11 has been suggested to play a role in the SUMOylation of mutant tau as well as excess normal tau and its subsequent degradation by proteasomes. This evidence concerns the gene MAPT and Alzheimer disease.